Alergia
Clínica
|
Respiratory Care
Treatment Updates
Future Treatments in
Allergic Disease CME
This activity
is not sanctioned by, nor a part of, the 56th
Annual Meeting of the American Academy of
Allergy, Asthma and Immunology here for more information on this
Medscape program.
Author: Thomas B. Casale, MD
Medical Writer: Robert F. McCarthy,
PhD
Release
Date: June 8, 2000
Valid for CME until June 8, 2001
|
| |
Anaphylaxis
By Phil Lieberman, MD
Objectives
Discern the pathogenesis of anaphylaxis and
anaphylactoid reactions.
Understand factors predisposing an individual to
anaphylaxis and anaphylactoid events.
Outline the differential diagnosis of anaphylaxis
and anaphylactoid events.
Determine the role of preventive measures, such
as pretreatment regimens, to avoid anaphylaxis
and anaphylactoid events.
Detail the appropriate therapy for anaphylaxis
and the anaphylactoid episode.
|
| |
Immunotherapy
and Allergen Avoidance for Allergic Airway
Disorders
By John W. Georgitis, MD, FCCP
Objectives
To list common categories and types of allergens
To describe early and late phase responses and
importance of mast cells in the allergic response
To list the measures of allergen avoidance
To examine the benefits and risks of
immunotherapy
To identify the advantages and disadvantages of
immunotherapy in asthma. |
| |
Hypersensitivity
Pneumonitis
By Mark
Schuyler, MD, FCCP
Objectives
Outline the clinical presentation of acute and
chronic hypersensitivity pneumonitis.
Understand the importance of a good history
relating symptoms to exposure to particular
environments.
Detail the role of serum antibody to appropriate
antigens in the diagnosis of hypersensitivity
pneumonitis.
Discuss the importance of removing antigen from
the patient's environment.
Determine the prognosis of acute and chronic
hypersensitivity pneumonitis.
|
|
Hypersensitivity
Pneumonitis (farmer's lung disease)
University of Iowa Faculty:
Gunnar Gudmundsson, M.D.
Jeff Wilson, M.D.
|
|
Evaluation
of Chronic Cough
University of Iowa Faculty:
Paul Jagielo, M.D.
|
|
Taking a
Targeted Occupational Respiratory History
By Paul Blanc, MD, FCCP
Objectives
Identify occupational risk factors.
Quantify relative exposure levels through
structured questions.
Assess links between specific respiratory
complaints and exposures on a case by case basis.
Consider "sentinel" conditions where
occupational factors are most likely.
Target questioning to elicit information
effectively.
|
| |
|
Immunotherapy and Allergen Avoidance for Allergic Airway
Disorders
By John W. Georgitis, MD,
FCCP |
Inmunología
Clínica
|
Wegener's
Granulomatosis
University of Iowa Faculty:
Rama Mallampalli, M.D.
Associate Professor
|
|
The International Thoracic
Teaching Resource
Diseases of
Altered Immunity
Jeffrey R. Galvin, M.D.
Michael P. D'Alessandro, M.D.
Yasayuki Kurihara, M.D.
Peer
Review Status: Internally Peer Reviewed
Acute eosinophilic
pneumonia
Allergic
Bronchopulmonary Asperillosis (ABPA)
Ankylosing
Spondylitis
Desquamative
Interstitial Pneumonitis
The hypereosinophilic
syndrome
Hypersensitivity
pneumonitis
Nocardiosis
Pneumocystis carinii
pneumonia
Relapsing
Polychondritis
Respiratory
Bronchiolitis
Sarcoidosis
Scleroderma
Systemic lupus
erythematosus (SLE)
Varicella-Zoster
pneumonia
|
|
The Many Faces of
Kawasaki Syndrome
DONALD Y. M.
LEUNG
H. CODY MEISSNER
National Jewish Medical and Research Center,
Denver
New England Medical Center, Boston
|
|
Integrins: The
Molecular Glue of Life
AMOS ETZIONI
Rambam Medical Center, Haifa, Israel
|
Inmunogenética
|
The Human Genome:
Information Content and Structure
DENNIS W. ROSS
University of North Carolina
|
|
The Prospects for
Gene Therapy
STEPHEN L. ECK
University of Pennsylvania
|
|
Biochips: An
Evolving Clinical Technology
ARIS PERSIDIS
RHeoGene LLC, Charlottesville, Va.
|
|
Cancer: The
Emerging Molecular Biology
DENNIS W. ROSS
University of North Carolina
|
|
The Prospects for
Antisense Therapy
ALAN M. GEWIRTZ
University of Pennsylvania
|
|
Bringing Genetic
Tests into the Clinic
NEIL A. HOLTZMAN
Johns Hopkins University
|
Medicina Respiratoria
|
Multimedia Files:
Lung Sounds
Chest
Auscultation
Gunnar Gudmundsson, M.D.
Tryggvi Ásmundsson, M.D.
National University Hospital of Iceland
Reykjavik, Iceland
|
|
The International
Thoracic Teaching Resource
A Multilingual Chest Imaging Database
Jeffrey
R. Galvin, M.D.
Professor of Radiology and Internal Medicine
The University of Iowa College of Medicine, Iowa
City, IA.
Michael P. D'Alessandro, M.D
Assistant Professor of Radiology
The University of Iowa College of Medicine, Iowa
City, IA.
Yasayuki Kurihara, M.D
Department of Radiology
St. Marianna University, Kawasaki City, Japan
|
|
Pulmonary
Developmental Anomalies
Uwa Aideyan, M.D.
Department of Radiology
University of Iowa
|
|
The International Thoracic
Teaching Resource: Chronic Obstructive Lung
Disease
Alpha-1-antitrypsin
deficiency
Jeffrey R. Galvin, M.D.
Michael P. D'Alessandro, M.D.
Yasayuki Kurihara, M.D.
|
|
Respiratory
Bronchiolitis: Etiology, Pathogenesis, and
Diagnosis
By Kevin K. Brown, MD and Eugene J.
Sullivan, MD
Objectives
To identify the exposures associated with
respiratory bronchiolitis-associated interstitial
lung disease (RB-ILD).
To recognize the symptoms and exam findings of RB-ILD.
To identify the common radiographic pattern of RB-ILD.
To recognize the physiologic abnormalities of RB-ILD.
To know the primary therapeutic interventions in
RB-ILD.
|
|
Adult Pulmonary Core
Curriculum
A
Complex Case of Mycobacterium Tuberculosis
Management and Drug Treatment
University of Iowa Faculty:
Charles S. Dayton, B.S., R.Ph.
Clinical Pharmacy Specialist
Department of Pharmaceutical Care
Adjunct Instructor
College of Pharmacy
J. Scott Ferguson, M.D.
Associate in Medicine
Department of Internal Medicine
Douglas B. Hornick, M.D.
Clinical Associate Professor of Medicine
Department of Internal Medicine
Michael W. Peterson, M.D.
Associate Professor of Medicine
Department of Internal Medicine
|
|
Augmentation
Therapy for a1-Antitrypsin
Deficiency
By Marc
S. Rovner, MD, FCCP, and James K. Stoller, MD,
FCCP
Objectives
Describe the basic physiology of a1-antitrypsin.
Outline the rationale for augmentation therapy in
a1-antitrypsin deficiency.
Define the different methods by which a1-antitrypsin
augmentation therapy can be used.
Detail the current recommendations and approach
to augmentation therapy in patients with a1-antitrypsin
deficiency.
Determine some of the treatment controversies and
available evidence supporting the use of
augmentation therapy in a1-antitrypsin
deficiency.
|
|
The Etiology
of Dyspnea During Exercise in COPD
By Denis E. O'Donnell, MD, FCCP, and Katherine
Webb, MSc
Objectives
Review the mechanical abnormalities that occur
during exercise in COPD.
Determine how these mechanical derangements might
give rise to respiratory discomfort.
Review the qualitative dimensions of exertional
dyspnea in COPD.
Discuss current concepts of the neurophysiologic
basis of exertional dyspnea in COPD.
Discern how mechanical factors can be favorably
manipulated to alleviate dyspnea and improve
exercise performance in COPD
|
|
University of Iowa Family
Practice Handbook, 3rd Edition, Chapter 1
Emergency
Medicine: Asthma/COPD/Dyspnea
Mark A. Graber, M.D.
Department of Family Medicine
University of Iowa
|
|
Corticosteroid
Therapy for COPD
By Dennis E. Niewoehner, MD,
FCCP
Objectives
Describe evolution of corticosteroid therapy for
COPD.
Present efficacy data of systemic corticosteroids
for stable COPD.
Present efficacy data of systemic corticosteroids
for COPD exacerbations.
Present efficacy data of inhaled corticosteroids
for long-term treatment of COPD.
Outline adverse effects from corticosteroids when
given for COPD.
|
|
Cystic
Fibrosis in the Adult
By Guillermo A. do Pico, MD, FCCP
Objectives
To discuss the genetics and pathogenesis of
cystic fibrosis.
To realize adult health issues.
To update knowledge on treatment of lung disease.
To explore newer therapies.
To discuss lung transplantation
|
|
Management
of Sleep Apnea/Hypopnea Syndrome
By M. Safwan Badr, MD
Objectives
Understand the role of modification of risk
factors in the treatment of sleep apnea.
Understand the role and limitations of
pharmacologic therapy.
Understand the potential role and indications for
various surgical procedures.
Understand the role of oral appliances in the
treatment of sleep apnea syndrome.
Understand the role of nasal CPAP therapy in the
treatment of sleep.
|
|
NEUMONÍA COMUNITARIA:
Dr. Joaquín Moris de la
Tassa
Hospital
de Cabueñes Gijón
Requiere inscripción en: http://www.medynet.com/elmedico/
|
|
EPOC 1ª parte
Dr. J. Gallardo Carrasco
Servicio de Medicina Interna
Hospital
Universitario. Guadalajara Universidad de Alcalá
de Henares
Requiere inscripción en: http://www.medynet.com/elmedico/
|
|
EPOC 2ª parte
Dr. J. Gallardo Carrasco
Servicio de Medicina Interna
Hospital
Universitario. Guadalajara Universidad de Alcalá
de Henares
Requiere inscripción en: http://www.medynet.com/elmedico/
|
|
Interpretation
of Pulmonary Function Tests: Spirometry
Esther Lum, M.D. and Thomas Gross, M.D.
Department of Internal Medicine
Division of Pulmonary, Critical Care, and
Occupational Medicine
The University of Iowa
|
|
Thoracopaedia - An
Imaging Encyclopedia of Pediatric Thoracic
Disease
Michael P.
D'Alessandro, M.D.
Associate
Professor of Radiology
Pediatric Radiology Section
Department of Radiology
University of Iowa College of Medicine
|
|
Smoking
Cessation
University
of Iowa Faculty:
Charles
S. Dayton, R.Ph.
Clinical Pharmacy Specialist
Department of Pharmaceutical Care
Adjunct Instructor
College of Pharmacy
Jeff
S. Wilson, M.D.
Associate Professor of Medicine
Department of Medicine
College of Medicine
|
|
Rinitis - Sinusitis
|
Approach to the
Management of Allergic Rhinitis
Certified
for 1 hour of Category 1 AMA Credit
Sponsored
by the University of Alabama School of Medicine
Division of Continuing Medical Education
Release
Date: June 30, 1999 , Expiration Date: June 30,
2001
|
|
Primary Care Clinical
Managment Module Volume 1
Update on the
Diagnosis and Treatment of Sinusitis CME
Author:
Jack B. Anon, MD
Writer: Margaret A. Varnell,
RN
Last Updated: September 1, 2000
Valid for CME until September 1, 2001
|
|
Rhinitis
Department of the Navy
Bureau of Medicine and Surgery
|
|
Asma
|
A Practical Guide
for Peak Expiratory Flow Monitoring in Asthma
Patients
Prasoon
Jain, MD and Mani S. Kavuru,MD
Cleveland Clinic Foundation
9500 Euclid Avenue
Cleveland, Ohio 44195
|
|
|
|
|
Controversies in
the Care of an Asthmatic Patient
Presented by:
|
American College of
Physicians and the Office of Continuing
Medical Education of the University of
Virginia School of Medicine
|
Lecturer
|
Steven M. Koenig, M.D.,
FCCP
|
|
|
Asthma
Education: Interactive Guidelines
Adapted in part from the National Asthma
Education Program 2 Guidelines
Michael W. Peterson, M.D.
Department of Internal Medicine
The University of Iowa College of Medicine
|
|
Peak Flow:
Myths & Truths
By
Susan Janson, DNSc, RN
Objectives
To describe peak expiratory flow (PEF) as a
measure of pulmonary function.
To list the advantages and limitations of long-term
PEF monitoring in clinical asthma management.
To analyze which patients are most likely to
benefit from PEF monitoring.
To list the key steps in training patients to use
a peak flowmeter correctly.
To describe how to use PEF to write an asthma
action plan.
|
|
Severe Asthma:
Clinical and Pathophysiologic Factors
Presented by: MCP Hahnemann
University School of Medicine (Primary Care Grand
Rounds)
Lecturer Sally Wenzel, M.D.
|
|
Progress in
the immunophysiology and epidemiology of asthma
David M. Lang,
M.D. , Assistant Professor of Medicine ,MCP
Hahnemann University
Jonathan S. Jaffee, M.D., Assistant Professor of
Medicine
LEARNING
OBJECTIVES
Introduction
Asthma Inflammation: The Role of Leukotrienes and
Cytokines
Asthma and the Urban Environment
CME Quiz
|
|
Respiratory Care Treatment
Updates
Optimum Use of Beta-Adrenergic
Receptor Agonists in Treatment of Asthma CME
This activity is not sanctioned by, nor a part
of, the American College of Allergy, Asthma &
Immunology. Click here for more information on this
Medscape program.
Authors: Myron Zitt, MD, and Sheldon C.
Siegel, MD
Medical Writer: Theodore Bosworth
Release Date: June 20, 2000
Valid for CME until June 20, 2001
|
|
Respiratory Care
Treatment Updates
Rationale for Anti-IgE
Therapy in Asthma CME
Author:
John V. Fahy, MD
Medical Writer: Robert McCarthy, PhD
Release
Date: June 29, 2000
Valid for CME until June 29, 2001
|
|
Asthma:
Evolving Anti-Inflammatory Therapy
Lewis J. Smith, MD, FCCP; and Peter H.S. Sporn,
MD, FCCP
Objectives
Define the essential pathophysiologic features of
asthma.
List the inflammatory cells and mediators that
contribute to the pathobiology of asthma and
understand the complex interactions that take
place between them.
Define the cellular and molecular mechanisms by
which inhaled corticosteroids produce their
beneficial effects in asthma and know when they
should be used.
Understand the biology of the leukotrienes
relevant to asthma including their synthesis and
the evolving role for the new antileukotriene
drugs (eg, receptor antagonists, synthesis
inhibitors) in treatment.
List the new and diverse anti-inflammatory
therapies being developed for the treatment of
asthma.
|
|
Corticosteroids
in Acute Respiratory Failure
By Michael A. Jantz, MD, and Steven A. Sahn, MD,
FCCP
Objectives
Outline which conditions causing acute
respiratory failure benefit from corticosteroids.
Describe the studies providing data for efficacy
of corticosteroids in these conditions.
Determine the biologic rationale for the use of
corticosteroids in ARDS.
Discern the complications of corticosteroid
therapy.
Provide recommendations for corticosteroid
regimens in treating these conditions causing
acute respiratory failure.
|
|
|
|
|
Update on
Research for Potential Asthma Therapies CME
David H.
Broide, MB, ChB
|
|
Dermatitis
Atópica
|
An
Introduction to Basic Dermatology
Warren Piette, M.D.
Department of Dermatology
The University of Iowa
|
| |
Pediatric Atopic
Dermatitis - New strategies
CME Online Symposium
For pediatricians, primary care physicians and
allergists
Adelaide A. Hebert, MD
Vice
Chairman, Department of Dermatology
Professor, Departments of Dermatology and
Pediatrics
The University of Texas-Houston Medical School
Houston, Texas
Mary K. Spraker, MD
Associate
Professor of Dermatology & Pediatrics
Emory U School of Medicine
Chief of Dermatology
Egleston Children's Hospital
Atlanta, Georgia
|
| |
|
Atopic Dermatitis: How to Incorporate Advances in Management
Stuart Leicht, MD; Matthew
Hanggi, MD |
Urticaria
|
Urticaria
and Angioedema
Department of the Navy
Bureau of Medicine and Surgery
|
Otras dermatosis
|
Current Treatment
Options in Psoriasis
AMOR KHACHEMOUNE
TANIA J. PHILLIPS
Boston University
|
Alergia Alimentaria
|
Food Allergy: From Biology
Toward Therapy
HUGH A. SAMPSON
Mount Sinai School of Medicine, New York
|
HIV-SIDA
|
Lung Disease
in Patients with AIDS
University
of Iowa Faculty:
Written by:
Lois J. Geist, M.D.
Associate Professor of Medicine
|
|
Management of the
Asymptomatic HIV-Infected Patient: An Update
ROBERT GAROFALO
HARVEY J. MAKADON
Harvard University
|
Laboratorio Clínico
|
The Clinical
Laboratory Improvement Act (CLIA)
and the Physician's Office Laboratory:
A Computer-Assisted CME Course
Ronald D. Feld, Ph.D.
Marian Schwabbauer,
Ph.D., CLDir(NCA)
John D. Olson, M.D.,
Ph.D.
The Department of Pathology
University of Iowa College of Medicine
Iowa City, Iowa
|
Medicina
basada en la evidencia
|
Curso electrónico
de Revisiones Sistemáticas
Este curso electrónico ha sido preparado por
el Centro Cochrane Español gracias al patrocinio
de Química Farmacéutica Bayer S.A. como una
contribución al desarrollo de la Colaboración
Cochrane.
|
| |
|
Curso Interactivo de Meta-análisis |
| |
Bioestadística
|
| |
|
|
|
|
|
Curso
electrónico de Revisiones Sistemáticas
Este curso electrónico ha
sido preparado por el Centro Cochrane Iberoamericano
|
Casos
Clínicos
Discusiones sobre Casos Clínicos
en importantes revistas internacionales
|
